SYSTEMIC CHARACTERIZATION OF KIDNEY CANCER TUMOR SUPPRESSORS IN MODULATING METASTASIS AND RESPONSE TO IMMUNOTHERAPY.
$1,283,229FY2021Defense Health AgencyDOD
Sloan-Kettering Institute For Cancer Research
Investigators
View source on USAspending →SYSTEMIC CHARACTERIZATION OF KIDNEY CANCER TUMOR SUPPRESSORS IN MODULATING METASTASIS AND RESPONSE TO IMMUNOTHERAPY. · GrantIndex